Nivolumab
Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1
CAS Number
946414-94-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1258030-01 0.02 mg (E-Coli)
Recombinant Mycobacterium sp. Ketol-acid reductoisomerase (ilvC)
Ask
View Details 
MBS1258030-02 0.02 mg (Yeast)
Recombinant Mycobacterium sp. Ketol-acid reductoisomerase (ilvC)
Ask
View Details 
MBS1258030-03 0.1 mg (E-Coli)
Recombinant Mycobacterium sp. Ketol-acid reductoisomerase (ilvC)
Ask
View Details MBS1258030-04 0.1 mg (Yeast)
Recombinant Mycobacterium sp. Ketol-acid reductoisomerase (ilvC)
Ask
View Details MBS1258030-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium sp. Ketol-acid reductoisomerase (ilvC)
Ask
View Details 
MBS1258030-06 0.02 mg (Mammalian-Cell)
Recombinant Mycobacterium sp. Ketol-acid reductoisomerase (ilvC)
Ask
View Details